Ben Gil Price - Nov 3, 2021 Form 4 Insider Report for NeuroBo Pharmaceuticals, Inc. (NRBO)

Role
CEO and President
Signature
/s/ Ben Gil Price
Stock symbol
NRBO
Transactions as of
Nov 3, 2021
Transactions value $
$0
Form type
4
Date filed
11/4/2021, 04:57 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NRBO Nonstatutory Stock Option (right to buy) Award $0 +617K $0.00 617K Nov 3, 2021 Common Stock 617K $2.04 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 266,666 shares subject to the option vest on the first anniversary of the vesting commencement date, November 3, 2021, and the remaining 350,000 shares subject to the option vest on the second anniversary of the vesting commencement date, subject to the Reporting Person's continuous service.